Cavassini M - Search Results

1

Dynamics of HIV latency and reactivation in a primary CD4+ T cell model.

Mohammadi P, di Iulio J, Muñoz M, Martinez R, Bartha I, Cavassini M, Thorball C, Fellay J, Beerenwinkel N, Ciuffi A, Telenti A. Mohammadi P, et al. Among authors: cavassini m. PLoS Pathog. 2014 May 29;10(5):e1004156. doi: 10.1371/journal.ppat.1004156. eCollection 2014 May. PLoS Pathog. 2014. PMID: 24875931 Free PMC article.

2

Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M; Swiss HIV Cohort Study. Kaufmann GR, et al. Among authors: cavassini m. Clin Infect Dis. 2005 Aug 1;41(3):361-72. doi: 10.1086/431484. Epub 2005 Jun 24. Clin Infect Dis. 2005. PMID: 16007534 Free article.

3

CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.

Wolbers M, Battegay M, Hirschel B, Furrer H, Cavassini M, Hasse B, Vernazza PL, Bernasconi E, Kaufmann G, Bucher HC; Swiss HIV Cohort Study. Wolbers M, et al. Among authors: cavassini m. Antivir Ther. 2007;12(6):889-97. Antivir Ther. 2007. PMID: 17926643

4

Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children.

Rudin C, Burri M, Shen Y, Rode R, Nadal D; Pediatric Infectious Disease Group of Switzerland; Swiss Mother and Child HIV Cohort Study (MoCHiV). Rudin C, et al. Pediatr Infect Dis J. 2008 May;27(5):431-7. doi: 10.1097/INF.0b013e3181646d5a. Pediatr Infect Dis J. 2008. PMID: 18382386

5

Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction.

Fayet A, Béguin A, de Tejada BM, Colombo S, Cavassini M, Gerber S, Eap CB, Telenti A, Buclin T, Biollaz J, Decosterd LA. Fayet A, et al. Among authors: cavassini m. Ther Drug Monit. 2008 Aug;30(4):511-22. doi: 10.1097/FTD.0b013e3181817318. Ther Drug Monit. 2008. PMID: 18641538

6

The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir.

Colombo S, Rauch A, Rotger M, Fellay J, Martinez R, Fux C, Thurnheer C, Günthard HF, Goldstein DB, Furrer H, Telenti A; Swiss HIV Cohort Study. Colombo S, et al. J Infect Dis. 2008 Sep 15;198(6):864-7. doi: 10.1086/591184. J Infect Dis. 2008. PMID: 18684101 Free article.

7

CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.

Khanna N, Opravil M, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Battegay M, Kaufmann GR; Swiss HIV Cohort Study. Khanna N, et al. Among authors: cavassini m. Clin Infect Dis. 2008 Oct 15;47(8):1093-101. doi: 10.1086/592113. Clin Infect Dis. 2008. PMID: 18783328 Free article.

8

In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function.

di Iulio J, Fayet A, Arab-Alameddine M, Rotger M, Lubomirov R, Cavassini M, Furrer H, Günthard HF, Colombo S, Csajka C, Eap CB, Decosterd LA, Telenti A; Swiss HIV Cohort Study. di Iulio J, et al. Among authors: cavassini m. Pharmacogenet Genomics. 2009 Apr;19(4):300-9. doi: 10.1097/FPC.0b013e328328d577. Pharmacogenet Genomics. 2009. PMID: 19238117

9

Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals.

Elzi L, Kaufmann G, Weber R, Fux CA, Cavassini M, Hirschel B, Vernazza P, Bernasconi E, Battegay M; Swiss HIV Cohort Study. Elzi L, et al. Among authors: cavassini m. HIV Clin Trials. 2009 Jul-Aug;10(4):207-14. doi: 10.1310/hct1004-207. HIV Clin Trials. 2009. PMID: 19723609

10

Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures.

Scherrer AU, von Wyl V, Fux CA, Opravil M, Bucher HC, Fayet A, Decosterd LA, Hirschel B, Khanlari B, Yerly S, Klimkait T, Furrer H, Ledergerber B, Günthard HF; Swiss HIV Cohort Study. Scherrer AU, et al. J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):464-71. doi: 10.1097/QAI.0b013e3181bca4ec. J Acquir Immune Defic Syndr. 2010. PMID: 19841590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

690 results

Search Page